Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Medical Specialties
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific, Inc. | -0.60% | 544.97 | 1.0% | $621.91m | |
| ABT | Abbott Laboratories | -0.91% | 109.22 | 0.8% | $585.36m | |
| DHR | Danaher Corp. | -0.98% | 255.53 | 0.7% | $572.59m | |
| MDT | Medtronic Plc | -0.93% | 90.53 | 0.6% | $550.73m | |
| ISRG | Intuitive Surgical, Inc. | 0.32% | 206.75 | 0.8% | $422.25m | |
| BSX | Boston Scientific Corp. | -0.55% | 37.80 | 1.0% | $341.88m | |
| ALGN | Align Technology, Inc. | 2.74% | 254.11 | 6.4% | $295.06m | |
| BDX | Becton, Dickinson & Co. | -1.50% | 248.03 | 1.0% | $283.25m | |
| SYK | Stryker Corp. | -0.94% | 201.95 | 1.3% | $280.50m | |
| EW | Edwards Lifesciences Corp. | 0.65% | 98.02 | 0.4% | $264.78m | |
| IDXX | IDEXX Laboratories, Inc. | 2.35% | 366.87 | 3.8% | $229.07m | |
| BAX | Baxter International, Inc. | -0.23% | 65.34 | 1.8% | $205.69m | |
| A | Agilent Technologies, Inc. | 1.09% | 120.51 | 1.7% | $197.45m | |
| DXCM | DexCom, Inc. | 1.07% | 78.46 | 1.9% | $197.40m | |
| SWAV | Shockwave Medical, Inc. | 1.61% | 201.82 | 0.0% | $184.35m |
Company Profile
Lucid Diagnostics, Inc. develops medical testing devices. It is a commercial-stage medical diagnostics technology company which focuses on gastroesophageal reflux disease (GERD), acid reflux or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma (EAC). The firm's products include EsoCheck is a cell collection device that is designed to collect cells of a targeted region of the esophagus without the need for endoscopy and EsoGuard is a laboratory developed test which analyzes methylated biomarkers. The company was founded on May 8, 2018 and is headquartered in New York, NY.